Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS

Journal of Analytical Toxicology

Volumn 31, Issue 7, 2007, Pages 359-368

  Feng, June ^a,c   Wang, Lanqing ^a   Dai, Ingrid ^b   Harmon, Tia ^a   Bernert, John T ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 7 AMINOFLUNITRAZEPAM; ALPRAZOLAM; AMOBARBITAL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZOYLECGONINE; BUTALBARBITAL; BUTALBITAL; COCAINE; CODEINE; FENCLONINE; FLUNITRAZEPAM; KETAMINE; METHAMPHETAMINE; MORPHINE; MORPHINE 3 GLUCURONIDE; N DESMETHYL FLUNITRAZEPAM; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; OXAZEPAM; OXYCODONE; PENTOBARBITAL; PHENOBARBITAL; SECOBARBITAL; TETRAHYDROCANNABINOLIC ACID; TRIAZOLAM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG URINE LEVEL; ELECTROSPRAY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITE; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; URINALYSIS;

EID: 34548858452     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.7.359     Document Type: Article

References (16)

1. SAMHSA. 2004 National household survey on drug abuse (NHSDA), 2005.
2. K.R. Allen, R. Azad, H.P. Field, and D.K. Blake. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann. Clin. Biochem. 42(4): 277-284 (2005).
3. H. Zhao, R. Brenneisen, A. Scholer, A.J. McNally, M.A. ElSohly, T.P. Murphy, and S.J. Salamone. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS. J. Anal. Toxicol. 25(4): 258-269 (2001).
4. G.W. Joe, W. Lehman, and D.D. Simpson. Addict death rates during a four-year posttreatment follow-up. Am. J. Public Health 72: 703-709 (1982).
5. M. Peat and A.E. Davis. Analytical considerations and approaches for drugs. In Drug Abuse Handbook, S.B. Karch, Ed. CRC Press, Boca Raton, FL, 1998, Chapter 10.3, pp 751-764.
6. A.G. Verstraete and F.V. Heyden. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine. J. Anal. Toxicol. 29: 359-364 (2005).
7. S. Cristoni, M. Cantu, L.R. Bernardi, P. Gerthoux, P. Mocarelli, M. Brambilla, E. Gonella, and F. Guidugli. Surface-activated chemical ionization ion trap mass spectrometry in the analysis of drugs in dilute urine samples. Part II: analysis of morphine and other street drugs. J. Mass Spectrom. 40(12): 1609-1617 (2005).
8. M. Gergov, I. Ojanpera, and E. Vuori. Simultaneous screening for 238 drugs in blood by liquid chromatography-ionspray tandem mass spectrometry with multiple-reaction monitoring. J. Chromatogr. B 795(1): 41-53 (2003).
9. R.A. Braithwaite, D.R. Jarvie, P.S. Minty, D. Simpson, and B.Widdop. Screening for drugs of abuse. I: Opiates, amphetamines and cocaine. Ann. Clin. Biochem. 32(Pt 2): 123-153 (1995).
10. H.K. Nordgren and O. Beck. Direct screening of urine for MDMA and MDA by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 27: 15-19 (2003).
11. L. Wang and J.T. Bernert. Analysis of 13 fentanils, including sufentanil and carfentanil, in human urine by liquid chromatography-atmospheric-pressure ionization-tandem mass spectrometry. J. Anal. Toxicol. 30(5): 335-341 (2006).
12. A. Cailleux, A. Le Bouil, B. Auger, G. Bonsergent, A. Turcant, and P. Allain. Determination of opiates and cocaine and its metabolites in biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry. J. Anal. Toxicol. 23(7): 620-624 (1999).
13. R. Dams, C.M. Murphy, W.E. Lambert, and M.A. Huestis. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17(14): 1665-1670 (2003).
14. X.H. Chen, J.P. Franke, J. Wijsbee, and R.A. de Zeeuw. Isolation of acidic, neutral, and basic drugs from whole blood using a single mixed-mode solid-phase extraction column. J. Anal. Toxicol. 16(6): 351-355 (1992).
15. J. Yawney, S. Treacy, K.W. Hindmarsh, and F.J. Burczynski. A general screening method for acidic, neutral, and basic drugs in whole blood using the Oasis MCX column. J. Anal. Toxicol. 26(6): 325-332 (2002).
16. 9-tetrahydrocannabinol-9-carboxylic acid. J. Anal. Toxicol. 29(7): 627-631 (2005).